Endo, Penwest grant 2 licenses to market generic Opana ER

06/8/2010 | Wall Street Journal, The

Endo Pharmaceuticals Holdings and Penwest Pharmaceuticals gave Impax Laboratories and Novartis' Sandoz separate licenses to market a generic version of Opana ER, an extended-release pain tablet.

View Full Article in:

Wall Street Journal, The